These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 3450848)

  • 21. Non-inferiority trials: the 'at least as good as' criterion.
    Laster LL; Johnson MF
    Stat Med; 2003 Jan; 22(2):187-200. PubMed ID: 12520556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual bioequivalence: what matters to the patient.
    Hauck WW; Anderson S
    Stat Med; 1991 Jun; 10(6):959; discussion 959-60. PubMed ID: 1876785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equivalence assessment for interchangeability based on two-sided tests.
    Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1312-31. PubMed ID: 25032976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of parametric and nonparametric two one-sided tests procedures for assessing bioequivalence of average bioavailability.
    Liu JP; Weng CS
    J Biopharm Stat; 1993 Mar; 3(1):85-102. PubMed ID: 8485538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consideration of individual bioequivalence.
    Anderson S; Hauck WW
    J Pharmacokinet Biopharm; 1990 Jun; 18(3):259-73. PubMed ID: 2380920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extension to the use of tolerance intervals for the assessment of individual bioequivalence.
    Esinhart JD; Chinchilli VM
    J Biopharm Stat; 1994 Mar; 4(1):39-52. PubMed ID: 8019583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statistical aspects of bioequivalence--a review.
    Pidgen AW
    Xenobiotica; 1992 Jul; 22(7):881-93. PubMed ID: 1455906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-sided hypothesis testing: simultaneous testing of superiority, equivalence and inferiority.
    Goeman JJ; Solari A; Stijnen T
    Stat Med; 2010 Sep; 29(20):2117-25. PubMed ID: 20658478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Power of the two one-sided tests procedure in bioequivalence.
    Phillips KF
    J Pharmacokinet Biopharm; 1990 Apr; 18(2):137-44. PubMed ID: 2348380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A permutation two one-sided tests procedure to detect minimal fold changes of gene expression levels.
    Liu JP; Liao CT; Chiu ST; Dai JY
    J Biopharm Stat; 2008; 18(5):808-26. PubMed ID: 18781518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exact calculation of power and sample size in bioequivalence studies using two one-sided tests.
    Shen M; Russek-Cohen E; Slud EV
    Pharm Stat; 2015; 14(2):95-101. PubMed ID: 25477145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sample size determination for the two one-sided tests procedure in bioequivalence.
    Liu JP; Chow SC
    J Pharmacokinet Biopharm; 1992 Feb; 20(1):101-4. PubMed ID: 1588502
    [No Abstract]   [Full Text] [Related]  

  • 33. Exact Power and Sample Size Calculations for the Two One-Sided Tests of Equivalence.
    Shieh G
    PLoS One; 2016; 11(9):e0162093. PubMed ID: 27598468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental design and statistical methods for classical and bioequivalence hypothesis testing with an application to dairy nutrition studies.
    Tempelman RJ
    J Anim Sci; 2004; 82 E-Suppl():E162-172. PubMed ID: 15471796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On a reasonable disaggregate criterion of population bioequivalence admitting of resampling-free testing procedures.
    Wellek S
    Stat Med; 2000 Oct; 19(20):2755-67. PubMed ID: 11033573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the use of one-sided statistical tests in biomedical research.
    Murphy R
    Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):109-114. PubMed ID: 28323356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sample size calculations for risk equivalence testing in pharmacoepidemiology.
    Tubert-Bitter P; Manfredi R; Lellouch J; Bégaud B
    J Clin Epidemiol; 2000 Dec; 53(12):1268-74. PubMed ID: 11146274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An approach for sample size determination of average bioequivalence based on interval estimation.
    Chiang C; Hsiao CF
    Stat Med; 2017 Mar; 36(7):1068-1082. PubMed ID: 28070984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical aspects of comparative bioavailability trials.
    Westlake WJ
    Biometrics; 1979 Mar; 35(1):273-80. PubMed ID: 583027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of pharmacokinetic interaction as an equivalence problem.
    Steinijans VW; Hartmann M; Huber R; Radtke HW
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S25-30. PubMed ID: 8793601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.